Transfusion of hydroxyethylated amylopectin-protected frozen blood in man. I. Plasma clearance and renal excretion of the cryoprotectant.
Vox Sang
; 36(6): 337-41, 1979.
Article
en En
| MEDLINE
| ID: mdl-91262
In man following the autologous transfusion of blood previously frozen with 14% low molecular weight-hydroxyethylated amylopectin (cryo-HES), the clearance of this material from the intravascular space was compound, and appeared to consist of exponential components. The overall half-life -- however, was 10.6 +/- 3.0 (SD) h. Approximately 17% of the total infused cryo-HES was excreted in the urine 1 h postinjection, and 40% by 72 h. The erythrocyte sedimentation rate (ESR) was not affected by the presence of this substance in the bloodstream of the recipient. The results indicate that cryo-HES is removed rapidly following the transfusion of blood previously frozen with this material.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Almidón
/
Transfusión Sanguínea
/
Derivados de Hidroxietil Almidón
/
Crioprotectores
/
Amilopectina
/
Riñón
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Vox Sang
Año:
1979
Tipo del documento:
Article
Pais de publicación:
Reino Unido